• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

ASCO24: BillionToOne unveils results from tumour profiling test comparison

cafead

Administrator
Staff member
  • cafead   Jun 05, 2024 at 11:12: AM
via While the advancement of comprehensive genomic profiling (CGP) ushers in a more targeted approach to treating patients with cancer, BillionToOne says its approach could overcome limitations present in some patients.

article source